Barclays’s Solesence Inc SLSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6K Sell
19,807
-3,775
-16% -$4.66K ﹤0.01% 4644
2026
Q1
$22.4K Sell
23,582
-25,162
-52% -$31.8K ﹤0.01% 4556
2025
Q4
$77.7K Sell
48,744
-161
-0.3% -$436 ﹤0.01% 4646
2025
Q3
$157K Sell
48,905
-136,243
-74% -$488K ﹤0.01% 4432
2025
Q2
$807K Buy
+185,148
New +$650K ﹤0.01% 3480

Other funds holding SLSN

Barclays's SLSN Position: Q2 2026 in Review

Barclays reduced its Solesence Inc (SLSN) stake by 16% in Q2 2026, selling an estimated $4.66K and leaving 19,807 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4644.

Barclays first reported a position in SLSN in Q2 2025 and has held it in 5 quarters since. The position peaked at $807K in Q2 2025. 44 funds tracked by Wall St. Rank hold SLSN as of Q2 2026.

  • Barclays held 19,807 shares of Solesence Inc worth $14.6K as of Q2 2026.
  • Barclays sold 3,775 Solesence Inc shares in Q2 2026, an estimated $4.66K.
  • Solesence Inc made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4644 holding.
  • Barclays first reported a position in Solesence Inc in Q2 2025 and has held it in 5 quarters since.
  • Barclays's Solesence Inc position peaked at $807K in Q2 2025.
  • 44 funds tracked by Wall St. Rank held Solesence Inc as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.